
|Articles|April 14, 2020
EPS Corp Offers CluePoints RBQM Solution
Advertisement
EPS Corporation, a Shinjuku-ku, Tokyo-based CRO, has reached an agreement to offer CluePoints’ Risk Based Quality Management (RBQM) solutions to its sponsors. The RBQM tools will complement either new or existing RBM processes through the CluePoints Central Monitoring Platform to allow EPS sponsors drive early risk detection, improve quality and enhance patient safety in clinical trials.
For the full release, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
5




